Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
AstraZeneca
Imperial College London
Eisai Inc.
University of California, Irvine
Qurient Co., Ltd.
Duke University
Essen Biotech
Essen Biotech
New Phase Ltd.
DualityBio Inc.
Grey Wolf Therapeutics
University of Nebraska